Day Trading Stocks & Futures

[sanju005ind]

aithe nenu kuda inka Telugu lone rastanu ikkada!

Ye basha aina parva ledu

 

[afin]

English please everyone. It is a request! I hope you all respect that on a forum like this.

 

[KAL.YUG]

Ishi khushi mein upper circuit toh banta hai

 

[TraderRavi]

Rakesh Jhunjhunwala's portfolio hit 28%; Ashish Dhawan, Dolly Khanna suffer

Amidst the massacre, the networth of high individual investors (HNIs) such as Rakesh Jhunjhunwala & Family, Ashish Dhawan, Anil Kumar Goel & Family, Ashish Ramchandra Kacholia and Dolly Khanna have taken a massive hit.

The big bull of Indian equity markets, Rakesh Jhunjhunwala & family, has lost Rs 3,554 crore thus far in CY20, with value their investments slipping below Rs 10,000 crore mark. Based on Thursday’s closing price, Rakesh Jhunjhunwala & family’s total investments in listed companies stood at Rs 8,925 crore, down 28 per cent as compared to Rs 12,480 crore at the end of December 2019.

According to data from the latest shareholding pattern where they held an over one percentage point stake reveals that these investors took a painful hit due to sharp correction in shares of mid-and small-cap companies. While the mid-cap index has slipped 27 per cent, the small-cap index has lost nearly 29 per cent during this period.

In Titan that has slipped 24 per cent to its 52-week low of Rs 900 per share, for instance, where Rakesh Jhunjhunwala along with his wife Rekha Jhunjhunwala, holds 6.69 per cent stake, the value erosion thus far in CY20 has been Rs 1,710 crore. Jhunjhunwala’s investment in Titan based on December 2019 quarter’s shareholding pattern now stands at Rs 5,344 crore.

NCC, Delta Corp, Karur Vysya Bank, Aptech and Jubilant Life Sciences are among those stocks from Jhunjhunwala’s portfolio that took a severe hit, falling more than 50 per cent during the period. However, Lupin, Escorts and Rallis India have outperformed the market by declining less than 20 per cent.

In percentage terms, Anil Kumar Goel & Seema Goel who hold stocks of sugar companies such as Dhampur Sugar, Triveni Engineering and Industries, Dwarikesh Sugar and Uttam Sugars in their portfolio, the average value erosion has been 49 per cent to Rs 453 crore. On the other hand, other investors such as Ashish Dhawan, Ashish Ramchandra Kacholia and Dolly Khanna have seen their portfolio value dip between 36 per cent and 44 per cent thus far in CY20.

While the jury is still out how long the health scare will continue to impact the markets, analysts at ICICI Securities suggest the real impact to come from the demand side due to the cascading impact of the slowdown. This can eventually lead to suppressed prices and, thereby, financial growth of most companies.

“Majority of the negative outcomes from Covid-19 in at least the next two quarters are already discounted across global indices. However, either any delay beyond that or a substantial increase in infection can result in more negative outcomes. Hence, the probability of further downsides in equity indices cannot be ruled out,” wrote Chirag Shah and Dhavan Shah of ICICI Securities in a note.

Meanwhile, the valuations of the mid-and small-cap segments has dipped below the long-term averages.

“Post market correction, current price-earnings (PE) of NSE Mid-cap Index is -33 per cent/-22 per cent versus its 5/10-yr average. For Nifty50, the same is -21 per cent/-15 per cent. On the other hand, the current PE for our Midcap coverage is -27 per cent/-1 per cent versus its 5/10-yr average,” says Sonali Salgaonkar, an analyst with Jefferies tracking these market segments.

https://www.business-standard.com/a...hawan-dolly-khanna-suffer-120032000371_1.html

 

[TraderRavi]

IDFC First Bank hits new low as MD & CEO Vaidyanathan sells 27 mn shares


Shares of IDFC First Bank tanked 10 per cent and hit a new low of Rs 18.60 on the BSE on Friday after the bank's Managing Director and Chief Executive Officer (MD & CEO), V Vaidyanathan, sold 27.56 million shares for approximately Rs 58 crore to close ESOP loan availed by him.


The bank said that Vaidyanathan intends to sell another about Rs 35 crore worth of stocks today (March 20, 2020) to entirely repay the residual ESOP (employee stock ownership plan) Loan taken for exercising his ESOP shares to release his pledged shares. He holds 42.35 million shares, representing 0.88 per cent stake, after yesterday’s sale.

In the past one month, IDFC First Bank's stock price has tanked 54 per cent, as compared to 32 per cent decline in the S&P BSE Sensex in the same period.


“The prices of the stock has come down recently due to the Coronavirus-related development in the stock market across all sectors including all Banks which resulted in margin call, and at this stage I decided to sell the stock to entirely square the ESOP Loans. With the sale of Rs 35 core expected today, my loans against shares will be NIL. I have no other loans other than a home loan,” V. Vaidyanathan said in a letter sent to the company.

“We are building a wonderful bank with strong trajectory of growth of branches, strong growth in retail loans, sharp improvement in CASA, with low NPA and high capital adequacy. All our trajectory strongly positive across all parameters. Hence I deeply regret sale of shares at this growth stage of our bank given the wonderful prospects, but I had to do the same to square the ESOP Loan. I believe there will be no need for me to sell any more shares in the foreseeable future,” he said.

At 10:08 am, the stock had erased its entire early morning losses and was trading 1 per cent higher at Rs 20.90 on the BSE, in line with the benchmark Sensex. Almost 35.7 million shares have changed hands on the counter on the NSE and BSE so far.

https://www.business-standard.com/a...t-bank-stock-hits-new-low-120032000338_1.html

 

[kharikumaar]

Rakesh Jhunjhunwala's portfolio hit 28%; Ashish Dhawan, Dolly Khanna suffer

Amidst the massacre, the networth of high individual investors (HNIs) such as Rakesh Jhunjhunwala & Family, Ashish Dhawan, Anil Kumar Goel & Family, Ashish Ramchandra Kacholia and Dolly Khanna have taken a massive hit.

The big bull of Indian equity markets, Rakesh Jhunjhunwala & family, has lost Rs 3,554 crore thus far in CY20, with value their investments slipping below Rs 10,000 crore mark. Based on Thursday’s closing price, Rakesh Jhunjhunwala & family’s total investments in listed companies stood at Rs 8,925 crore, down 28 per cent as compared to Rs 12,480 crore at the end of December 2019.

According to data from the latest shareholding pattern where they held an over one percentage point stake reveals that these investors took a painful hit due to sharp correction in shares of mid-and small-cap companies. While the mid-cap index has slipped 27 per cent, the small-cap index has lost nearly 29 per cent during this period.

In Titan that has slipped 24 per cent to its 52-week low of Rs 900 per share, for instance, where Rakesh Jhunjhunwala along with his wife Rekha Jhunjhunwala, holds 6.69 per cent stake, the value erosion thus far in CY20 has been Rs 1,710 crore. Jhunjhunwala’s investment in Titan based on December 2019 quarter’s shareholding pattern now stands at Rs 5,344 crore.

NCC, Delta Corp, Karur Vysya Bank, Aptech and Jubilant Life Sciences are among those stocks from Jhunjhunwala’s portfolio that took a severe hit, falling more than 50 per cent during the period. However, Lupin, Escorts and Rallis India have outperformed the market by declining less than 20 per cent.

In percentage terms, Anil Kumar Goel & Seema Goel who hold stocks of sugar companies such as Dhampur Sugar, Triveni Engineering and Industries, Dwarikesh Sugar and Uttam Sugars in their portfolio, the average value erosion has been 49 per cent to Rs 453 crore. On the other hand, other investors such as Ashish Dhawan, Ashish Ramchandra Kacholia and Dolly Khanna have seen their portfolio value dip between 36 per cent and 44 per cent thus far in CY20.

While the jury is still out how long the health scare will continue to impact the markets, analysts at ICICI Securities suggest the real impact to come from the demand side due to the cascading impact of the slowdown. This can eventually lead to suppressed prices and, thereby, financial growth of most companies.

“Majority of the negative outcomes from Covid-19 in at least the next two quarters are already discounted across global indices. However, either any delay beyond that or a substantial increase in infection can result in more negative outcomes. Hence, the probability of further downsides in equity indices cannot be ruled out,” wrote Chirag Shah and Dhavan Shah of ICICI Securities in a note.

Meanwhile, the valuations of the mid-and small-cap segments has dipped below the long-term averages.

“Post market correction, current price-earnings (PE) of NSE Mid-cap Index is -33 per cent/-22 per cent versus its 5/10-yr average. For Nifty50, the same is -21 per cent/-15 per cent. On the other hand, the current PE for our Midcap coverage is -27 per cent/-1 per cent versus its 5/10-yr average,” says Sonali Salgaonkar, an analyst with Jefferies tracking these market segments.

https://www.business-standard.com/a...hawan-dolly-khanna-suffer-120032000371_1.html

so sad, sirf 9000 crores? wonder how they are going to avoid hunger now.

 

[kharikumaar]

i bought 9000 ce at 94 and sold at 104. current price 250

 

[TraderRavi]

i bought 9000 ce at 94 and sold at 104. current price 250

250 par bech paate to fir aap kharikumar thodi na rehte phir to ambanikumar
ya phir jhunjhunkumar ban jaate

 

[KAL.YUG]

so sad, sirf 9000 crores? wonder how they are going to avoid hunger now.

They will take Loan Against Shares .... spend small sum on food and rest they will start buying stocks on every fall
.... after 2-4 years 25,000 - 30,000 Cr

 

[TraderRavi]

COVID-19 infections haven't reached community level in India, says Harsh Vardhan


https://www.moneycontrol.com/news/w...htra-delhi-pune-mumbai-karnataka-5053051.html